[PDF][PDF] Advancements in myocardial infarction management: exploring novel approaches and strategies
P Sachdeva, K Kaur, S Fatima, FNU Mahak, M Noman… - Cureus, 2023 - cureus.com
In the landscape of healthcare, the management of myocardial infarction (MI) stands as a
pivotal challenge and a critical juncture where advancements are reshaping the trajectory of …
pivotal challenge and a critical juncture where advancements are reshaping the trajectory of …
[HTML][HTML] Inflammaging in Multidrug-Resistant Sepsis of Geriatric ICU Patients and Healthcare Challenges
NR Kumar, TA Balraj, KK Shivashankar, TC Jayaram… - Geriatrics, 2024 - mdpi.com
Multidrug-resistant sepsis (MDR) is a pressing concern in intensive care unit (ICU) settings,
specifically among geriatric patients who experience age-related immune system changes …
specifically among geriatric patients who experience age-related immune system changes …
Galectin-3 in Blood Serum and Lymphocytes as a Marker of Myocardial Damage in Patients with Arterial Hypertension and COVID-19
Background: The constant increase of arterial hypertension and the development of
pathology at an earlier age are global healthcare problems that cause damage to vital …
pathology at an earlier age are global healthcare problems that cause damage to vital …
[HTML][HTML] 脓毒症心肌损伤生物标志物最新进展
刘艳 - Advances in Clinical Medicine, 2023 - hanspub.org
近几年在危重症病人当中因脓毒症的发病率和死亡率逐渐上升对其早期诊断和治疗被引起越来
越多的关注, 早期识别感染对脓毒症心肌损伤患者的临床病程和结局至关重要 …
越多的关注, 早期识别感染对脓毒症心肌损伤患者的临床病程和结局至关重要 …
Pathological changes of biochemical, hematological and coagulation analyses in patients with COVID-19 disease
The identification of patients with poor prognosis and early detection of COVID-19 disease
complications are made possible by pathological analyses of routine hematological …
complications are made possible by pathological analyses of routine hematological …